Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Huemer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Mbio|September 23, 2020
Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus InfectionAnna M Sobieraj, Markus Huemer, Léa V Zinsli, et al.
Mbio|January 26, 2024
MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infectionsChristian Roehrig, Markus Huemer, Dominique Lorgé, et al.
Mbio|September 28, 2023
Systemic application of bone-targeting peptidoglycan hydrolases as a novel treatment approach for staphylococcal bone infectionAnja P Keller, Markus Huemer, Chun-Chi Chang, et al.
Science Signaling|January 3, 2023
Serine-threonine phosphoregulation by PknB and Stp contributes to quiescence and antibiotic tolerance in <i>Staphylococcus aureus</i>Markus Huemer, Srikanth Mairpady Shambat, Sanne Hertegonne, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 6, 2022
Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentationsJulian Bär, Mathilde Boumasmoud, Srikanth Mairpady Shambat, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2021
Molecular reprogramming and phenotype switching in <i>Staphylococcus aureus</i> lead to high antibiotic persistence and affect therapy successMarkus Huemer, Srikanth Mairpady Shambat, Judith Bergada-Pijuan, et al.
Mbio|April 16, 2020
Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureusChristian Röhrig, Markus Huemer, Dominique Lorgé, et al.
Msphere|August 27, 2024
Investigating group A <i>Streptococcus</i> antibiotic tolerance in necrotizing fasciitisNadia Keller, Mathilde Boumasmoud, Federica Andreoni, et al.
Clinical & Translational Immunology|December 23, 2021
Blunted sFasL signalling exacerbates TNF-driven neutrophil necroptosis in critically ill COVID-19 patientsTiziano A Schweizer, Srikanth Mairpady Shambat, Clement Vulin, et al.
Mbio|October 13, 2025
Alpha-toxin-elicited CX<sub>3</sub>CL1 release in <i>Staphylococcus aureus</i> pneumonia impairs bactericidal function of human monocytesSrikanth Mairpady Shambat, Puran Chen, Rocky M Barilla, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Mbio|September 23, 2020
Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus InfectionAnna M Sobieraj, Markus Huemer, Léa V Zinsli, et al.
Mbio|January 26, 2024
MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infectionsChristian Roehrig, Markus Huemer, Dominique Lorgé, et al.
Mbio|September 28, 2023
Systemic application of bone-targeting peptidoglycan hydrolases as a novel treatment approach for staphylococcal bone infectionAnja P Keller, Markus Huemer, Chun-Chi Chang, et al.
Science Signaling|January 3, 2023
Serine-threonine phosphoregulation by PknB and Stp contributes to quiescence and antibiotic tolerance in <i>Staphylococcus aureus</i>Markus Huemer, Srikanth Mairpady Shambat, Sanne Hertegonne, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 6, 2022
Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentationsJulian Bär, Mathilde Boumasmoud, Srikanth Mairpady Shambat, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2021
Molecular reprogramming and phenotype switching in <i>Staphylococcus aureus</i> lead to high antibiotic persistence and affect therapy successMarkus Huemer, Srikanth Mairpady Shambat, Judith Bergada-Pijuan, et al.
Mbio|April 16, 2020
Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureusChristian Röhrig, Markus Huemer, Dominique Lorgé, et al.
Msphere|August 27, 2024
Investigating group A <i>Streptococcus</i> antibiotic tolerance in necrotizing fasciitisNadia Keller, Mathilde Boumasmoud, Federica Andreoni, et al.
Clinical & Translational Immunology|December 23, 2021
Blunted sFasL signalling exacerbates TNF-driven neutrophil necroptosis in critically ill COVID-19 patientsTiziano A Schweizer, Srikanth Mairpady Shambat, Clement Vulin, et al.
Mbio|October 13, 2025
Alpha-toxin-elicited CX<sub>3</sub>CL1 release in <i>Staphylococcus aureus</i> pneumonia impairs bactericidal function of human monocytesSrikanth Mairpady Shambat, Puran Chen, Rocky M Barilla, et al.
Pageof 3